Brainsway P/E Ratio

Brainsway (BWAY) currently reports a P/E ratio of 45.25. That is above the Healthcare sector average of 22.57. Use the charts on this page to explore Brainsway's P/E ratio history and peer comparisons.

Brainsway's P/E ratio of 45.25 is higher than the Healthcare sector average of 22.57. That is roughly 100.5% above the sector mean. A reading higher peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

The P/E ratio is a valuation multiple that relates Brainsway's market price to a fundamental measure such as earnings, sales, or book value. At 45.25, BWAY can look expensive or cheap only in context — versus its own history, growth rate, and Healthcare peers. Higher multiples often price in stronger expected growth; lower ones can signal value or concern.

Start with the current P/E ratio of 45.25, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is 22.57. From there, open related valuation or income-statement pages for Brainsway, and consider following BWAY for alerts when major investors trade the stock.

Brainsway is classified in the Healthcare sector. On P/E ratio, it currently shows 45.25 versus a sector average near 22.57. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing BWAY with unrelated industries.